Pharmacodynamics of Ertapenem Posted on April 16, 2019 at 3:11 pm.Written by Spero Therapeutics View Presentation Post navigation Activity of tebipenem, an oral carbapenem, against multidrug-resistant urinary tract infection-causing pathogens with characterized resistance mechanisms collected in Europe and the United States in 2016Antimicrobial activity evaluation of tebipenem (SPR859), an orally available carbapenem, against a global set of Enterobacteriaceae, including a challenge set of organisms
